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Abstract
This study investigates the existence of economies of scale in the provision of breast and cervical 
cancer screening and diagnostic services by state National Breast and Cervical Cancer Early 
Detection Program (NBCCEDP) grantees. A translog cost function is estimated as a system with 
input factor share equations. The estimated cost function is then used to determine output levels 
for which average costs are decreasing (i.e., economies of scale exist). Data were collected from 
all state NBCCEDP programs and District of Columbia for program years 2006–2007, 2008–2009 
and 2009–2010 (N =147). Costs included all programmatic and in-kind contributions from federal 
and non-federal sources, allocated to breast and cervical cancer screening activities. Output was 
measured by women served, women screened and cancers detected, separately by breast and 
cervical services for each measure. Inputs included labor, rent and utilities, clinical services, and 
quasi-fixed factors (e.g., percent of women eligible for screening by the NBCCEDP). 144 out of 
147 program-years demonstrated significant economies of scale for women served and women 
screened; 136 out of 145 program-years displayed significant economies of scale for cancers 
detected. The cost data were self-reported by the NBCCEDP State programs. Quasi-fixed inputs 
were allowed to affect costs but not economies of scale or the share equations. The main analysis 
accounted for clustering of observations within State programs, but it did not make full use of the 
panel data. The average cost of providing breast and cervical cancer screening services decreases 
as the number of women screened and served increases.
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1 Introduction
Public health programs are increasingly being asked to demonstrate that they are allocating 
resources efficiently [1]. Doing so can be especially challenging for programs that distribute 
resources across many sites for implementation (e.g., Federal programs operated through 
State public health agencies). Public health programs, without a competitive market for their 
“output” (e.g., number of women screened for cancer), have to create and rely upon 
mechanisms and incentives other than profit maximization to track costs and measure 
efficiency. An efficient program is one that is minimizing its average total cost for a given 
level of output, which is equivalent to maximizing its output for a given level of 
expenditures (e.g., costs per woman screened). Thus, a sufficient summary measure for 
operating efficiency, and to represent programs’ “production” technology, is a program’s 
cost per unit of output.
Assuming programs operate efficiently, the cost function can be used to examine how 
average costs vary with the level of output. If a public health program exhibits economies of 
scale, then average cost should decrease as output increases. For example, a screening 
program in which cost per woman decreases as more women are screened exhibits 
economies of scale. Economies of scale can result from fixed costs, such as purchases of 
mammography equipment, being spread out over more women served. Economies of scale 
also occur when operational efficiency (e.g., management, information systems) improves as 
more women are served and screened. Economies of scale imply that improving reach to 
people in need of services could simultaneously improve cost efficiency.
This study examines the existence of economies of scale for the National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP), a program created in 1990 by the 
U.S. Congress under the Breast and Cervical Cancer Mortality Prevention Act (Public Law 
101–354) and run by the Centers for Disease Control and Prevention (CDC). The 
NBCCEDP’s goal is to reduce disparities in breast and cervical cancer mortality rates and to 
provide low-income uninsured women with greater access to breast and cervical cancer 
screening and diagnostic services. Since 2000, with the implementation of the Breast and 
Cervical Cancer Prevention and Treatment Act (Public Law 106–354), women diagnosed 
with cancer through the NBCCEDP are enrolled in State Medicaid programs to receive 
treatment. As the largest organized cancer screening program in the United States, the 
NBCCEDP is a complex system of 68 individual screening programs, operated in all 50 
States, the District of Columbia (DC), 5 U.S. territories, and 12 American Indian and Native 
Alaskan tribal organizations [2]. Detailed descriptions of the NBCCEDP have been 
presented previously [2, 3]. Preliminary evidence for a subset of NBCCEDP programs 
suggested that average costs are inversely related to the number of services provided, which 
is suggestive of economies of scale [4]. However, to our knowledge, no flexible cost 
function has yet been applied to ascertain the existence of economies scale in delivering 
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preventive health services in the NBCCEDP or other mass screening programs. In this study, 
we investigated the extent of economies of scale in the provision of breast and cervical 
cancer screening and diagnostic services (i.e., output) in NBCCEDP programs.
2 Methods
A cost function represents the least-cost way for a program to produce a given level of 
output (e.g., number of women served) given the prices of inputs into the screening process 
(e.g., labor) [5]. A flexible translog cost function was estimated as a system with input factor 
(e.g., labor) share equations using cost and output data collected from all State programs and 
DC for program years 2006–2007, 2008–2009, and 2009–2010 [5]. The estimated cost 
function was then used to determine output levels (e.g., number of women served) for which 
average costs are decreasing or increasing. The estimated translog cost function treated 
breast and cervical services as separate outputs. This approach captured the differences in 
screening and diagnostic technologies between the two types of cancer. It also allowed us to 
test whether average costs decline with increases in both services (economies of scope). We 
also controlled for other constraints on production that are external to the programs and 
fixed in the short run (i.e., quasi-fixed inputs), such as the size of the population eligible for 
NBCCEDP.
Under the assumption that programs are minimizing costs for a given level of services, the 
estimated cost function provides a complete description of how resources are utilized to 
produce breast and cervical cancer screening and diagnostic services. Cost function 
estimation does not require an assumption of profit maximization, which makes it ideal for 
public programs like the NBCCEDP. It does, however, assume that programs are cost 
minimizers. Although there are no explicit economic incentives to minimize costs (i.e., a 
profit motive), other factors like external review and public audits could lead to cost 
minimization [4]. Unlike a production function approach, the cost function approach more 
easily allows the analysis of multiple outputs. Furthermore, the assumption of fixed input 
prices under competitive market conditions is more plausible than the assumption of fixed 
input quantities. We empirically tested properties of the estimated cost function that have to 
hold under the cost minimization condition.
2.1 Translog cost function
To determine whether the NBCCEDP exhibits economies of scale, we estimated the 
minimum average cost function for the program using the following transcendental 
logarithmic (or translog) cost function:
(1)
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where C is total cost, Y is the vector of outputs (e.g., breast and cervical services), P is the 
vector of input prices, Q is a vector of quasi-fixed inputs that affect programmatic delivery 
(e.g., population of women aged 18 to 64), and T is the time period of the observation [5, 6]. 
The translog cost function does not impose any a priori restrictions on the production 
technology. To avoid proliferation of parameters with our relatively small estimation sample, 
we did not interact the quasi-fixed inputs with outputs or prices. As is customary, we 
assumed that the cross-output and cross-price effects are symmetric (i.e., βij = βji and αij = 
αji). Economic theory suggests that cost functions are homogenous of degree one—a Z 
percent increase in all input prices will raise total costs by Z percent:
Substituting the translog cost function (Eq. 1) in the expression above implies, with a little 
algebra, the following set of constraints on the parameters [5]:
(2)
(3)
and
(4)
In addition to these constraints, the structure of the translog cost function implies a specific 
relationship between the share of costs attributable to each input and the existing parameters. 
Shephard’s lemma shows that the derived demand for input Xi can be computed by partially 
differentiating the cost function with respect to the input price Pi:
Using Shepard’s lemma, the rules of differentiation for natural logs, and the translog cost 
function in Eq. (1) yields:
(5)
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for every i, where Si is the proportion of C attributable to input i. We calculated the shares (S 
i) from the data by dividing the cost of input i by the total cost. Including these share 
equations improves the efficiency of the model because they contain no additional 
parameters; thus, we estimated Eqs. 1 and 5 as a system of seemingly unrelated regressions 
[7]. We dropped one share equation from the system because the shares must sum to one [5]. 
This system of equations was estimated via maximum likelihood using Stata 12 [8]. To 
account for the use of pooled panel data, we clustered standard errors at the State level. 
Before estimating this system of equations, we normalized each variable around its 
geometric mean. This step ensures that each variable is equal to zero at its arithmetic mean 
after logarithmic transformation [6].
2.2 Economies of scale and scope
The multi-output translog cost function allows a formal test for both economies of scale and 
scope. Economies of scale can be measured by the change in total cost when all outputs are 
increased by the same proportion. Differentiating the cost function (Eq. 1) with respect to all 
output yields:
ε is the elasticity of total cost with respect to output. If this elasticity is less than one, then 
the proportional increase in costs is less than the proportional increase in output and 
economies of scale exist, or
(6)
Because all variables are normalized to zero about their geometric means, for the average 
program Eqs. 1 and 6 simplify to
(7)
On the other hand, economies of scope exist if a program can produce multiple outputs at a 
lower cost than it could if it produced only a single output. This will be true if the marginal 
cost of producing output i (Yi) decreases as production of output j (Yj) increases:
(8)
where i≠j. In the translog cost function (Eq. 1), this is approximately equivalent to
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(9)
where i≠j [6].
2.3 Tests for cost minimization and functional form
The translog cost function requires the assumption that programs minimize costs. As noted, 
factors like external review and public audits could lead to cost minimization despite the 
absence of free-market pressures [4]. There is evidence that cost minimization does occur in 
nonmarket health care systems [9]. We formally tested whether or not State-level programs 
in the NBCCEDP minimize costs.
Cost minimization requires that four properties are satisfied. As is common in translog 
estimation, we assumed linear homogeneity (Eq. 2) and empirically tested for the remaining 
properties. The second property, monotonicity in output, requires that costs increase with 
increased output:
(10)
for every observation. If costs did not increase as outputs increase (i.e., the program could 
produce more at no extra cost), that would signal inefficient uses of resources. Input costs 
would be wasted when they could have been used to generate more output, violating cost 
minimization.
The third property, monotonicity in input prices, requires that costs increase (or stay the 
same) with increased input prices—that is, that Eq. 5 is strictly nonnegative for every 
observation and input price i. If not, (i.e., input prices increase and overall costs decrease), 
then there must be some other mix of the same inputs that would have generated more 
output before, which would not be cost minimizing.
Finally, concavity in input prices requires that costs increase at a decreasing rate (or stay the 
same) as input prices increase. If input prices doubled, and the program did not alter its input 
mix, then cost would grow linearly with factor prices. Since the program can always choose 
not to alter its behavior, its costs cannot grow faster than linearly with changes in input 
prices. If the program takes advantage of substitution opportunities, costs will grow slower 
than linearly with input prices. The second derivative (Hessian) matrix of the translog cost 
function (Eq. 1) with respect to the vector of input prices (P) is
(11)
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which must be negative semidefinite for concavity in input prices. To test this, we evaluated 
the eigenvalues of Eq. 11 at the program mean [9].
2.4 Data sources
2.4.1 Costs—Cost data for each of the NBCCEDP programs were collected using the Cost 
Assessment Tool (CAT), which was developed to ensure accurate and consistent cost 
reporting from each of the 68 programs administered by CDC [3, 10]. Data were collected 
annually for three program years: 2006–2007, 2008–2009, and 2009–2010. Five programs 
reported data from 2007 to 2008 in lieu of 2009–2010. We pooled the 3 years in the analysis. 
Programs reported all programmatic costs and in-kind contributions. In-kind contributions 
were any non-cash contributions to the program that could be given cash value (e.g., 
differentials between charges and Medicare rates or donated space). The NBCCEDP 
program-years included in our analysis were for established programs that had been 
operating for more than 20 years. Thus, implementation (i.e., start-up) costs were not 
included in the analysis. Programs were required to allocate expenditures to a list of specific 
program activities, such as screening and diagnostic follow-up or case management. 
Estimates of the relative focus on breast or cervical care for each of these activities were 
obtained. The categories in which these costs were reported allowed us to allocate 
expenditures to specific inputs in the share equations.
After all the data were compiled, a series of quality checks was conducted to identify any 
obvious errors in the data. These errors were corrected via direct correspondence with the 
programs in question. Because of inconsistent data reporting, we excluded tribes and 
territories from our analysis, leaving 51 programs spanning the 50 States and the District of 
Columbia, each with 3 years of data. Because NBCCEDP programs are not allowed to 
exceed their funding levels, program-years in which total costs differed by more than 10 % 
from adjusted annual funding were also excluded due to quality concerns (N =6). This left a 
total of 147 program-years in our final, unbalanced sample. Costs were updated to 2010 U.S. 
dollars using the overall consumer price index [11].
2.4.2 Output—Our primary definition of output is women served, which is the total 
number of women who were screened by the program or referred to the program for 
diagnostic follow-up only. We also explored two alternative definitions of output in our 
analyses. The number of women screened denotes women who were screened for breast or 
cervical cancer by the program, excluding women who were screened elsewhere and 
referred to the NBCCEDP for diagnostic follow-up. The number of breast and cervical 
cancers detected includes both in situ and invasive cancers that were identified by screening 
through the NBCCEDP. Two program-years had no cancers detected, leaving 145 program-
years for analyses with cancers detected as the output measure. In our main analysis, we 
included two separate measures for each output above, one each for breast and cervical 
services.
Data on the number of women served or screened and the number of cancers detected were 
obtained from the NBCCEDP’s surveillance database and the CAT. The NBCCEDP 
database reports the values of output that are attributable to Federal funds, whereas the CAT 
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reports these values for non-Federal funds. Using our output definitions, a woman who is 
screened for both breast and cervical cancer would be counted twice, once for each 
screening test received in the program. Although the NBCCEDP’s primary focus is on 
cancer screening, it also spends resources on non-screening activities that support their 
primary screening goals, including outreach and public awareness. Because the ultimate goal 
of the programs is to provide services, we implicitly assumed that all costs are attributable to 
screening-related activities [4].
2.4.3 Price of labor—As a proxy for the price of labor, we constructed a price index using 
data on employment from the CAT and State-level wages from the Bureau of Labor 
Statistics [12]. In the CAT, programs were required to list the number of employees on 
payroll and the type of work that each of these employees conducted. Using this 
information, we identified seven different occupations that were included in the BLS data 
and that correspond to the types of employees listed in the CAT (e.g., registered nurse, 
statistician; see Table 1). To obtain a representative market basket for employment, we 
calculated the proportion of total employment that each of these occupations constitutes at 
the national level in the NBCCEDP. We then calculated a weighted average of median 
hourly wages for each State from yearly BLS wage data using these proportions as weights. 
States with missing wage data for a given occupation (N =17 program-years with one 
missing occupation) were assigned the average wage for the Census region.
2.4.4 Price of rent and utilities—For the price of rent and utilities (i.e., capital), we 
adapted the methods employed in the American Chamber of Commerce Research 
Association (ACCRA) Cost of Living Index [13]. The ACCRA Cost of Living Index 
consists of survey data that report the price of food, housing, utilities, transportation, and 
health care in cities and towns across the United States. Weights for the ACCRA Cost of 
Living Index are derived from the BLS’ Consumer Expenditure Survey.
For our analysis, we focused on housing and utility prices. The housing component of the 
index reflects the price of renting or buying a new residence. Although the NBCCEDP is 
subject to commercial real estate prices, evidence suggests that residential and commercial 
real estate prices are correlated [14]. The utilities component of the index is constructed 
using the costs of electricity and telephone service.
We calculated housing and utility indices using ACCRA data from years 2006–2010. We 
limited our analysis to locations that had an observation in each of the 4 program-years of 
data. Using the same methods and weights used by ACCRA, we constructed price indices 
that coincided with the NBCCEDP program years for each location in the data. State-level 
price indices were obtained by calculating the average index value in each State, weighing 
each location with population data from the U.S. Census Bureau [15].
2.4.5 Price of clinical services—The prices of clinical services in the NBCCEDP are 
tied to Medicare reimbursement rates. We used Medicare Geographic Adjustment Factors 
(GAFs) to account for regional variation in prices. Medicare reimbursement rates are 
adjusted using three Geographic Pricing Cost Indices (GPCIs). Every procedure covered by 
Medicare is divided into physician work, practice expense, and malpractice insurance 
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components, which vary by the amount of labor, skill, equipment, and risk involved in the 
procedure. Each of these three components is adjusted using the GPCIs to determine the 
reimbursement rate for a certain procedure in a given location. On average, the physician 
work, practice expense, and malpractice insurance GPCIs constitute 52.47 %, 43.67 %, and 
3.87 % of the final cost share, respectively [16]. We used these values as weights to combine 
the GPCIs and obtain the GAF for each Medicare locality. State-level estimates were 
obtained by averaging the GAFs for all localities in each State with equal weight.
2.4.6 Quasi-fixed inputs—Our cost function includes a set of quasi-fixed inputs that 
affect the ability of State programs to deliver care. These inputs are fixed and out of the State 
programs’ control, at least in the short-run (i.e., quasi-fixed). We evaluated breast and 
cervical screening compliance rates, breast and cervical cancer incidence rates, a measure of 
limited access to primary care services, the percentage of women eligible for breast or 
cervical cancer screening by the NBCCEDP, the State population of women aged 18–64, 
State population density, and a time trend for inclusion in the model. Because of limited 
sample size, we used Akaike and Bayesian information criteria to determine which variables 
would be included in our final specification. The final model includes a time trend; the 
population of women aged 18–64; State population density; and the percentage of women 
eligible for cervical cancer screening by the NBCCEDP, estimated using the Current 
Population Survey [15, 17]. Women are eligible for the NBCCEDP if they are within the 
target age range, are uninsured or underinsured, and have a household income under 185–
250 % of the Federal poverty line, depending on State criteria [18].
2.5 Sensitivity analyses
In addition to our main analysis, we performed a series of sensitivity analyses to explore the 
impact of alternative assumptions on the measure of scale economies. In the first sensitivity 
analysis, we included in-kind contributions in the dependent variable. In another, we 
estimated Eq. 1 in a random effects framework, omitting the share equations because of 
computational constraints. We also estimated the main analysis while excluding observations 
from New York and California, which had substantially larger output than other State-level 
programs.
In a final sensitivity analysis, we estimated single output models that examined breast and 
cervical services of the NBCCEDP separately. In this case, we allocated all costs to breast or 
cervical care using activity totals and program-reported estimates of programmatic emphasis 
on these activities and used these values as our dependent variables. We included a single 
output in Eqs. 1 and 5 and added a fourth quasi-fixed input to the model. This quasi-fixed 
input was the number of women served for breast or cervical cancer over the total number of 
women served, which served as a measure of program focus. Lastly, we used the population 
of women aged 40–64 and the number of women eligible for breast cancer screening as 
quasi-fixed inputs in our breast-specific model.
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3 Results
3.1 Descriptive
Programs’ costs and outputs varied considerably (Table 2). Average annual program costs 
were $5.51 million (standard deviation [SD]=$7.70 million) without in-kind contributions 
included and $6.59 million (SD=$8.17 million) with in-kind contributions. The average 
number of women served was 13,037 (SD=26,239) for breast cancer services and 8,489 
(SD=11,095) for cervical cancer services. Clinical costs constituted the majority of total 
program costs (52.0 %; SD=14.8 %) and the majority of breast cancer service costs (57.2 %; 
SD=14.7 %).
3.2 Main analysis
Statistically significant economies of scale existed for the average program-year for each 
output measure, with the largest economies of scale for cancers detected and the smallest 
economies of scale for women served (Table 3). There were no significant economies or 
diseconomies of scope for the average program-year among the output measures. At the 
program-year level, 144 out of 147 observations demonstrated significant economies of scale 
for women served and women screened at the 95 % confidence level for a one-sided test of 
Eq. 7. Similarly, 136 out of 145 program-years displayed significant economies of scale for 
cancers detected. No observations demonstrated significant diseconomies of scale.
In terms of programs, the vast majority demonstrated economies of scale in all three 
program years in our analysis: 86 % for women served, 84 % for women screened, and 78 % 
for cancers detected (Table 4). Only one program for women served and one program for 
cancers detected had no significant economies of scale in any of the three program years 
studied.
In all models, price effects were significant and positive. Higher State populations 
significantly increase total cost, whereas the results for the other quasi-fixed inputs were 
inconclusive. On the basis of the Akaike Information Criteria (AIC) and the Bayesian 
Information Criteria (BIC), the women served model provided the best fit of the three 
models, and as a result we limit our discussion of the sensitivity analyses to this output 
measure.
3.3 Tests for cost minimization and functional form
Tests failed to reject the null hypothesis that programs in the NBCCEDP minimize costs. 
Monotonicity in output (Eq. 10) holds for all program-years for women served, 143 out of 
147 program-years for women screened, and 134 out of 145 program-years for cancers 
detected. Monotonicity in output (Eq. 10) was not significantly positive or negative for all 
other program-years. Similarly, all fitted share equations were positive, indicating 
monotonicity in input prices. The eigenvalues of Eq. 11 were not significantly positive, so 
we failed to reject that the matrix was negative semi-definite, and consequently, that the data 
were concave in input prices. Thus, we conclude that the data do not violate the cost 
minimization assumption and that the translog cost function is an acceptable functional form 
for this analysis.
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3.4 Sensitivity analyses
Table 5 reports the results of alternative two-output models with women served as the output 
measure. All alternative specifications estimated statistically significant economies of scale 
for the average program-year. Including in-kind contributions in the dependent variable 
along with total cost slightly increased the economies of scale and economies of scope 
estimates. Estimating Eq. 1 in a random effects framework indicated substantially increased 
economies of scale relative to the main analysis and rejected economies of scope. The AIC 
and BIC for the random effect model are very different from the other models because the 
random effect model was estimated without the share equations. Dropping New York and 
California program-years, which are large programs and potential outliers, did not 
substantially alter the results of the main analysis (Table 5). The AIC and BIC indicate that 
the main analysis provided the best fit of the data.
Single-output models, which evaluated women served for breast and cervical cancer 
screening and diagnostic services separately, estimated significant economies of scale for 
breast and cervical services (Table 6). These estimates provide evidence of product-specific 
economies of scale. In both models, the variable representing the share of all women served 
for that particular output was insignificant. This is consistent with the insignificant 
economies of scope that were observed in most of the two-output models. Figures 1 and 2 
illustrate the average cost curve, its relationship with the program-year observations, and the 
levels of output at which we detect significant economies of scale for breast and cervical 
cancer screening, respectively. In these figures, we hold all price and quasi-fixed variables 
constant at the mean.
4 Discussion
This study finds strong and robust evidence of economies of scale in the provision of breast 
and cervical cancer screening and diagnostic services by NBCCEDP programs. This implies 
that the average cost of providing breast and cervical cancer screening services decreases as 
the number of women screened and served increases. In fact, 98 % (144/147) of the 
program-years we analyzed were operating at a level where economies of scale had not been 
exhausted. These economies of scale could result from improved operating efficiency or the 
ability to spread the costs of large investments over more women. Given current screening 
penetration rates by State NBCCEDP programs, opportunities exist to increase the share of 
eligible women screened [18]. Increasing the number of women these programs serve could 
reach more women in need and improve cost efficiency at the same time.
The results of this study are consistent with those of a previous study that found that average 
costs were lower for programs that provided more services [4]. Relative to that previous 
study, this study analyzed more complete cost data using the flexible cost function, which 
has never been applied to the NBCCEDP programs over a longer time period. Our approach 
improves upon the existing literature in several ways. First, our estimation sample was more 
inclusive than previous analyses of NBCCEDP costs [3, 4]. We analyzed data from all State 
programs and DC, each for up to 3 years [10]. Second, we had a more complete picture of 
the cost structure of the programs, including non-Federal funding and services, in-kind 
Trogdon et al. Page 11
Health Care Manag Sci. Author manuscript; available in PMC 2018 March 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
contributions, cost shares for major input factors such as labor and clinical services, and 
allocations to breast and cervical services.
Together, this and a previous study suggest that economies of scale that may have been 
present early in the development of the NBCCEDP are still present even in the more mature 
programs [4]. In addition, we failed to reject our assumption of cost minimization by 
NBCCEDP State programs. Evidence of cost minimization by publicly funded programs has 
been found in the hospital industry as well [9]. The consistency with earlier studies provides 
support for our finding that as more women are screened in the NBCCEDP program the cost 
per additional woman screened declines significantly.
The results presented in this study are subject to several limitations. First, the cost data were 
self-reported by the NBCCEDP State programs. Although several internal and external 
validity checks were included as part of the cost collection, some cost categories did not 
have another source of information against which to verify the programs’ reports (e.g., non-
CDC funding, in-kind contributions) [10]. Results for economies of scale were robust to 
alternative treatment of these cost categories. Second, quasi-fixed inputs were allowed to 
affect costs but not economies of scale or the share equations. This assumption is restrictive 
but necessary because of the limited sample size; full interactions of the quasi-fixed inputs 
with the other variables would have led to an unreasonable number of parameters to 
estimate. Finally, although the main analysis accounted for clustering of observations within 
State program, it did not make full use of the panel data. We estimated a random effect 
model without the share equations, but algorithms do not yet exist to estimate a system of 
random effect equations with cross-equation constraints.
Cost function estimation is a valid approach to assessing economies of scale in publicly 
funded programs. This study’s analysis will be used to calculate alternative cost indices to 
help CDC make resource allocation decisions and analyze the results of those decisions. We 
hope that it will allow the NBCCEDP to improving operating efficiency and provide breast 
and cervical cancer screening services to more women in need.
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Fig. 1. 
Average cost per woman served—breast cancer screening. The average cost curve is 
represented by the blue line, and the program-year observations are shown as red points on 
the graph. We find economies of scale for all levels of output below the value indicated by 
the drop line. All levels of output above this value demonstrate neither significant economies 
nor diseconomies of scale
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Fig. 2. 
Average cost per woman served—cervical cancer screening. The average cost curve is 
represented by the blue line, and the program-year observations are shown as red points on 
the graph. We find economies of scale for all levels of output below the value indicated by 
the drop line. All levels of output above this value demonstrate neither significant economies 
nor diseconomies of scale
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Table 1
Crosswalk for BLS occupations
CAT occupation BLS occupation
Administrative assistant Secretaries and administrative assistants, except legal, medical, and executive
Case manager Registered nurses
Data manager Database administrators
Info tech specialist Medical records and health information technicians
Program director General and operations managers
Program manager Medical and health services managers
Public health nurse Registered nurses
Services coordinator Registered nurses
Epidemiologist/statistician Statisticians
BLS bureau of labor statistics; CAT cost assessment tool
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Table 2
Descriptive analysis of the NBCCEDP State Programs 2006–2010 (N =147 program-years)
Mean SD Min Max
Dependent variables
 Total cost (millions $) 5.51 7.70 0.46 54.41
 Total cost and in-kind (millions $) 6.59 8.17 0.54 54.41
 Total cost, breast (millions $) 3.85 6.12 0.37 43.59
 Total cost, cervical (millions $) 1.66 1.84 0.09 11.55
 Share of cost—labor (%) 19.4 10.8 3.6 65.2
 Share of cost—clinical (%) 52.0 14.8 5.1 81.7
 Share of cost—clinical, breast (%) 57.2 14.7 6.4 91.0
 Share of cost—clinical, cervical (%) 41.0 17.8 3.1 81.2
Output variables
 Women served, breast 13,037 26,239 708 200,281
 Women served, cervical 8,489 11,095 280 85,422
 Women screened, breast 10,681 25,545 222 197,833
 Women screened, cervical 7,612 10,575 87 83,127
 Cancers detected, breast 129 132 4 857
 Cancers detected, cervical 121 202 0 1,410
Price variables
 Wage index 29.78 3.77 23.06 39.86
 Capital price index 111.08 34.69 78.34 232.89
 Geographic Adjustment Factor index 98.87 6.60 90.45 128.80
Quasi-fixed inputs
 Eligible population (%), breast 7.0 2.8 1.8 16.3
 Eligible population (%), cervical 9.4 3.6 2.1 21.0
 State population of women aged 40–64 (millions) 1.01 1.09 0.09 5.84
 State population of women aged 18–64 (millions) 1.90 2.12 0.16 11.54
 Population density (inhabitants/square mile) 383 1,369 1 9,822
 Percentage served for breast 57.0 9.7 24.9 79.3
 Percentage served for cervical 43.0 9.7 20.7 75.1
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Table 4
Number of programs displaying significant economies of scale by program outcome measure
Number of program-years
Percent of programs (N)
Served Screened Detected
3 86 (44) 84 (43) 78 (40)
2 12 (6) 14 (7) 12 (6)
1 0 (0) 2 (1) 8 (4)
0 2 (1) 0 (0) 2 (1)
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Table 6
Single-output models, women served
Breast Cervical
Point estimate P value Point estimate P value
Economies of scale if >0 0.399 0.000 0.245 0.007
Percentage of women served for output measure −0.187 0.329 0.311 0.194
AIC −443.5 −343.8
BIC −398.6 −298.9
AIC Akaike information criteria; BIC Bayesian information criteria
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